About: Clinical and radiologic features of the first cured Coronavirus disease 2019 (COVID-19) patient in Guangzhou City, China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical and radiologic features of the first cured Coronavirus disease 2019 (COVID-19) patient in Guangzhou City, China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Clinical and radiologic features of the first cured Coronavirus disease 2019 (COVID-19) patient in Guangzhou City, China
Creator	Liu, Jin-Xin Feng, Guo-Kai Gan, Qing-Xin Li, Mei-Yu Wang, Guan-Nan
Source	PMC
abstract	To determine changes in clinical and radiologic findings associated with Coronavirus disease 2019 (COVID-19) from diagnosis to recovery, we retrospectively reviewed the diagnosis and treatment records of the first patient cured of COVID-19 in Guangzhou. A 55-year-old woman from Wuhan was admitted to the hospital isolation ward with the chief complaint of “cough for 11 days and once fever 8 days ago” on January 22, 2020. COVID-19 was laboratory confirmed by reverse transcription polymerase chain reaction (RT-PCR) assay, and she received conventional antiviral therapy, such as moxifloxacin, traditional Chinese medicine, and arbidol. Repeat chest-computed tomography (CT) scans were performed on days 13 and 19 of her illness. The former showed radiologic findings, including ground-glass opacities (GGOs), which revealed viral pneumonia; the latter revealed that the previous lesions had been significantly absorbed. The lesions on CT scans were consistent with the changes in the course of disease. Some drugs, such as traditional Chinese medicine and arbidol, might play an important role in the recovery of COVID-19 patients. This study provides some new insights into the formulation of a timely and effective diagnostic and therapeutic strategy to cure patients with COVID-19. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s42058-020-00045-z) contains supplementary material, which is available to authorized users.
has issue date	2020-08-25(xsd:dateTime)
bibo:doi	10.1007/s42058-020-00045-z
has license	no-cc
sha1sum (hex)	26ea0cf7876d41982bf53625695f7cbbd8f5f744
schema:url	https://doi.org/10.1007/s42058-020-00045-z
resource representing a document's title	Clinical and radiologic features of the first cured Coronavirus disease 2019 (COVID-19) patient in Guangzhou City, China
has PubMed Central identifier	PMC7447088
schema:publication	Chin J Acad Radiol
resource representing a document's body	covid:26ea0cf7876d41982bf53625695f7cbbd8f5f744#body_text
is schema:about of	named entity 'conventional' named entity 'diagnosis' named entity 'COVID-19' named entity 'PCR' named entity 'AGO' named entity 'chain reaction' named entity 'absorbed' named entity 'patients' named entity 'moxifloxacin' named entity 'fever' named entity 'Wuhan' named entity 'patient' named entity 'COVID-19' named entity 'arbidol' named entity 'ground-glass opacities' named entity 'arbidol' named entity 'viral pneumonia' named entity 'CT scans' named entity '8 days' named entity 'isolation ward' named entity 'chief complaint' named entity 'Wuhan' named entity 'arbidol' named entity 'COVID-19' named entity 'oxygen saturation' named entity 'biochemical' named entity 'RT-PCR' named entity 'chest CT' named entity 'January 30' named entity 'infection' named entity 'lung tissue' named entity 'lactic acid' named entity 'COVID-19' named entity 'CT scanner' named entity 'Nan Wang' named entity 'Guangzhou' named entity 'People's Republic of China' named entity 'arbidol' named entity 'People's Republic of China' named entity 'oropharyngeal' named entity 'COVID-19' named entity '8 days' named entity 'RT-PCR' named entity 'Guangzhou' named entity 'lesion' named entity 'afebrile' named entity 'afebrile' named entity 'sore throat' named entity 'oseltamivir' named entity 'isolation ward' named entity '1, 2' named entity 'dry cough' named entity 'COVID-19' named entity 'lung' named entity 'phosphate' named entity 'arbidol' named entity 'respiratory symptoms' named entity 'January 11' named entity 'COVID-19' named entity 'upper lobes' named entity 'biochemistry' named entity 'respiratory symptoms' named entity 'National Health Commission' named entity 'COVID-19' named entity 'lung' named entity 'oseltamivir' named entity 'lung inflammation' named entity 'January 23' named entity 'pneumonia' named entity 'COVID-19' named entity 'radiograph' named entity 'sample size' named entity 'Pneumonia' named entity 'lung' named entity 'CT scans' named entity 'viral infection' named entity 'left lung' named entity 'hypoxia' named entity 'antiviral'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software